Enodia Therapeutics Appoints Henrik Torp Nielsen as Chief Financial Officer to Support Corporate Growth and Strategic Development

Paris, France--(Newsfile Corp. - October 29, 2026) - Enodia Therapeutics, a biotechnology company developing small-molecule therapies targeting a unique form of protein degradation at the point of synthesis, appointed Henrik Torp Nielsen as Chief Financial Officer. With nearly two decades of experience in biopharma finance and operations, Mr. Nielsen will lead Enodia's financial strategy and operations as the company advances its proprietary Sec61 platform. Enodia's approach selectively...

2026-10-29 7:20 AM EDT